Wenqian Chen
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Optimizing Linezolid Dosing in Lung Transplant Recipients: Population Pharmacokinetics, Target Attainment, and Thrombocytopenia Risk Assessment.
Journal: Journal of clinical pharmacology
Published: September 09, 2025
Efficacy and toxicity analysis of ganciclovir in patients with cytomegalovirus lung infection: what is new for target range of therapeutic drug monitoring.
Journal: Microbiology spectrum
Published: July 08, 2025
Establishment and validation of a predictive nomogram for voriconazole-associated liver injury in lung transplant patients.
Journal: International journal of clinical pharmacy
Published: March 27, 2025
Application of artificial intelligence and machine learning in lung transplantation: a comprehensive review.
Journal: Frontiers in digital health
Published: February 26, 2025
Correction: A genotype-guided prediction model for the incidence of persistent acute kidney injury following lung transplantation.
Journal: BMC nephrology
Published: February 25, 2025
Simultaneous determination of three β-Lactam/β-lactamase inhibitor combinations in critically ill patients by UPLC-MS/MS.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published: August 22, 2024
Population Pharmacokinetic and Pharmacodynamic of Atorvastatin in Chinese Lung Transplant Recipients.
Journal: Journal of clinical pharmacology
Published: August 15, 2024
Renal Replacement Therapy as a New Indicator of Voriconazole Clearance in a Population Pharmacokinetic Analysis of Critically Ill Patients.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 24, 2024
A fully validated LC‑MS/MS method for quantifying bevacizumab in plasma samples from patients with NSCLC and its implications in therapeutic drug monitoring.
Journal: Oncology letters
Published: September 01, 2023
A fully validated method for simultaneous determination of icotinib, osimertinib, gefitinib and O-desmethyl gefitinib in human plasma using UPLC-MS/MS for therapeutic drug monitoring.
Journal: Journal of pharmaceutical and biomedical analysis
Published: August 13, 2023
Last Updated: 09/26/2026